ATE239077T1 - Erzeugung von diversität in kombinatorischen banken - Google Patents

Erzeugung von diversität in kombinatorischen banken

Info

Publication number
ATE239077T1
ATE239077T1 AT98910631T AT98910631T ATE239077T1 AT E239077 T1 ATE239077 T1 AT E239077T1 AT 98910631 T AT98910631 T AT 98910631T AT 98910631 T AT98910631 T AT 98910631T AT E239077 T1 ATE239077 T1 AT E239077T1
Authority
AT
Austria
Prior art keywords
ligands
banks
combinatory
creating diversity
phagemid
Prior art date
Application number
AT98910631T
Other languages
English (en)
Inventor
John Collins
Peter Roettgen
Original Assignee
Cosmix Molecular Biolog Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cosmix Molecular Biolog Gmbh filed Critical Cosmix Molecular Biolog Gmbh
Application granted granted Critical
Publication of ATE239077T1 publication Critical patent/ATE239077T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C40COMBINATORIAL TECHNOLOGY
    • C40BCOMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B40/00Libraries per se, e.g. arrays, mixtures
    • C40B40/02Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/10Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034Isolating an individual clone by screening libraries
    • C12N15/1037Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/66General methods for inserting a gene into a vector to form a recombinant vector using cleavage and ligation; Use of non-functional linkers or adaptors, e.g. linkers containing the sequence for a restriction endonuclease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Oscillators With Electromechanical Resonators (AREA)
  • Geophysics And Detection Of Objects (AREA)
  • Steroid Compounds (AREA)
  • Dram (AREA)
  • Semiconductor Memories (AREA)
  • Fishing Rods (AREA)
AT98910631T 1997-01-31 1998-02-02 Erzeugung von diversität in kombinatorischen banken ATE239077T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP97101539 1997-01-31
PCT/EP1998/000533 WO1998033901A2 (en) 1997-01-31 1998-02-02 Generation of diversity in combinatorial libraries

Publications (1)

Publication Number Publication Date
ATE239077T1 true ATE239077T1 (de) 2003-05-15

Family

ID=8226431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98910631T ATE239077T1 (de) 1997-01-31 1998-02-02 Erzeugung von diversität in kombinatorischen banken

Country Status (11)

Country Link
EP (2) EP0968283B1 (de)
JP (1) JP2001509672A (de)
CN (1) CN1246150A (de)
AT (1) ATE239077T1 (de)
AU (1) AU749249B2 (de)
CA (1) CA2279341A1 (de)
DE (1) DE69814059T2 (de)
DK (1) DK0968283T3 (de)
ES (1) ES2199431T3 (de)
IL (1) IL131075A0 (de)
WO (1) WO1998033901A2 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002225914A1 (en) * 2000-12-08 2002-06-18 Alexion Pharmaceuticals, Inc. Plasmid vectors
DE10145553B4 (de) * 2001-09-16 2006-06-08 Gene Architects Ag Nukleinsäure für einen Klonierungsvektor
EP1384779A1 (de) * 2002-07-26 2004-01-28 Cosmix Molecular Biologicals GmbH Methode zur Generierung von Molekülen mit spezifischen Eigenschaften durch Rekombination und Selektion
EP1384780A1 (de) * 2002-07-26 2004-01-28 Cosmix Molecular Biologicals GmbH Methode zur Generierung von Molekülen mit spezifischen Eigenschaften durch Rekombination und Selektion
EP1398375A1 (de) * 2002-09-13 2004-03-17 Cosmix Molecular Biologicals GmbH Recombinationsverfahren für Rekombination von verschiedenen Polynukleotidfragmenten
DE10337407A1 (de) * 2003-08-13 2005-03-10 Transmit Technologietransfer Klonierungssystem
EP2940138B1 (de) 2014-04-30 2018-02-28 Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. Phagen-Anzeigebibliothek
WO2017174809A1 (en) 2016-04-08 2017-10-12 Phico Therapeutics Ltd Modifying bacteriophage
PT3440200T (pt) 2016-04-08 2021-04-30 Phico Therapeutics Ltd Bacteriófago modificado

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61132187A (ja) * 1984-11-30 1986-06-19 Banyu Pharmaceut Co Ltd 新規コスミドベクタ−及びそれを用いる遺伝子バンクの製造方法
IL99552A0 (en) * 1990-09-28 1992-08-18 Ixsys Inc Compositions containing procaryotic cells,a kit for the preparation of vectors useful for the coexpression of two or more dna sequences and methods for the use thereof
IL99553A0 (en) * 1990-09-28 1992-08-18 Ixsys Inc Compositions containing oligonucleotides linked to expression elements,a kit for the preparation of vectors useful for the expression of a diverse population of random peptides and methods utilizing the same
FR2715940B1 (fr) * 1994-02-10 1996-04-26 Pasteur Merieux Serums Vacc Procédé de préparation d'une banque multicombinatoire de vecteurs d'expression de gènes d'anticorps, banque et systèmes d'expression d'anticorps "coliclonaux" obtenus.
US5605793A (en) * 1994-02-17 1997-02-25 Affymax Technologies N.V. Methods for in vitro recombination
EP0699750A1 (de) * 1994-06-07 1996-03-06 Gesellschaft für biotechnologische Forschung mbH (GBF) Eine Sammling an Phagemiden, eine Sammling von Escherichia coli Zellen die diese Phagemide tragen, eine Sammling an Phagemid-Partikeln die daraus hergestellt würden und Phagemid-Partikel die durch dieses Verfahren erhalten würden
US5702892A (en) * 1995-05-09 1997-12-30 The United States Of America As Represented By The Department Of Health And Human Services Phage-display of immunoglobulin heavy chain libraries

Also Published As

Publication number Publication date
ES2199431T3 (es) 2004-02-16
DE69814059T2 (de) 2004-05-19
AU749249B2 (en) 2002-06-20
IL131075A0 (en) 2001-01-28
AU6495198A (en) 1998-08-25
DE69814059D1 (de) 2003-06-05
CA2279341A1 (en) 1998-08-06
CN1246150A (zh) 2000-03-01
WO1998033901A9 (en) 1999-08-05
EP0968283B1 (de) 2003-05-02
DK0968283T3 (da) 2003-08-25
EP1302540A3 (de) 2003-11-05
WO1998033901A2 (en) 1998-08-06
EP0968283A2 (de) 2000-01-05
JP2001509672A (ja) 2001-07-24
WO1998033901A3 (en) 1999-06-17
EP1302540A2 (de) 2003-04-16

Similar Documents

Publication Publication Date Title
Capra et al. Light chain sequences of human IgM cold agglutinins
PT788509E (pt) Derivados peptidicos terapeuticos
ATE239077T1 (de) Erzeugung von diversität in kombinatorischen banken
NO961115L (no) Humane metabotrope glutamatreseptorsubtyper (HMR4, HMR6, HMR7) og relaterte DNA forbindelser
NO2017028I1 (no) eftrenonacog alfa eller et biotilsvarende legemiddel ihht Artikkel 10(4) av Directive 2001/83/EC, som beskyttet av basispatentet.
ATE223229T1 (de) Zusammensetzungen aus konjugaten des stabilen, aktiven, menschlichen ob proteins mit der fc kette von immunoglobulinen und damit zusammenhängende verfahren
EA200100365A1 (ru) Синтазы
EP0352000A3 (de) Retrovirale, Protease bindende Peptide
EP0724456A4 (de) Antikörper gegen cd40
DE69637480D1 (de) Bioaktive il-12 fusionsproteine
DE69434758D1 (de) Hybride toxine
EP0706657A4 (de) Wechselwirkungen von inhibierungsproteinen
ATE229542T1 (de) Fusionspolypeptid zur beeinflussung von wechselwirkungen zwischen proteinen
ATE404583T1 (de) Funktionelle antagonisten von hedgehog-aktivität
CA2143125A1 (en) Antibodies specific for a haemostatic protein, their use for isolating intact protein, haemostatic compositions devoid of proteolytic cleavage products of the protein
UA65561A (en) Therapeutic agent for lymphatic tumors
WO1994020512A3 (en) Analogs for specific oligosaccharide-protein interactions and uses therefor
ATE110074T1 (de) Quinolyloxazol-2-one, nützlich als proteinkinase- c-inhibitoren.
ES2058479T3 (es) Compuestos peptidicos.
DK0889957T3 (da) Subtilisindimer med forbedret aktivitet og fremgangsmåde til fremstilling deraf
NZ336781A (en) Fibronectin binding protein compositions, antibodies thereto, and methods of use
NO996384D0 (no) Fartoey for seismiske undersoekelser
WO1998046632A3 (de) Inhibitoren für den urokinaserezeptor
DE69823225D1 (de) Fusionsproteine, bestehend aus proteinaseinhibitoren
ATE398287T1 (de) Wechselwirkungen der katalytischen untereinheit der proteinphosphatase 1

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0968283

Country of ref document: EP

REN Ceased due to non-payment of the annual fee